Neoadjuvant chemoradiotherapy to convert borderline-resectable, locally-advanced esophageal carcinoma to resectable disease.

被引：1
|
作者：
Horne, Zachary D.
Sun, Weijing
Gibson, Michael K.
Pennathur, Arjun
Luketich, James D.
Greenberger, Joel S.
机构：
[1] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Univ Hosp Cleveland, Case Comprehens Canc Ctr, Med Ctr, Cleveland, OH 44106 USA
[4] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[5] Univ Pittsburgh, Div Thorac Surg, Pittsburgh, PA USA
[6] Univ Pittsburgh, Med Ctr Canc Pavil, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e15500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15500
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Hosogi, Hisahiro
    Yoshida, Shinya
    Sakaguchi, Masazumi
    Kanaya, Seiichiro
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (12) : 3040 - 3042
  • [22] Neoadjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Hisahiro Hosogi
    Shinya Yoshida
    Masazumi Sakaguchi
    Seiichiro Kanaya
    Journal of Gastrointestinal Surgery, 2023, 27 : 3040 - 3042
  • [23] Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer
    Malolan S Rajagopalan
    Dwight E Heron
    Rodney E Wegner
    Herbert J Zeh
    Nathan Bahary
    Alyssa M Krasinskas
    Barry Lembersky
    Randall Brand
    A James Moser
    Annette E Quinn
    Steven A Burton
    Radiation Oncology, 8
  • [24] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [25] Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma:A meta-analysis
    Hai-Lin Jin
    World Journal of Gastroenterology, 2009, 15 (47) : 5983 - 5991
  • [26] Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis
    Jin, Hai-Lin
    Zhu, Hong
    Ling, Ting-Sheng
    Zhang, Hong-Jie
    Shi, Rui-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (47) : 5983 - 5991
  • [27] Comparison of the treatment outcomes of different neoadjuvant chemoradiotherapy regimens for resectable locally advanced esophageal cancer
    Park, Hyunki
    Yang, Kyungmi
    Noh, Jae Myoung
    Shim, Young Mog
    Kim, Hong Kwan
    Choi, Yong Soo
    Cho, Jong Ho
    Sun, Jong-Mu
    Jung, Hyun Ae
    Park, Sehhoon
    Park, Hana
    Oh, Dongryul
    JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (11) : 1745 - 1751
  • [28] Comparison of the treatment outcomes of different neoadjuvant chemoradiotherapy regimens for resectable locally advanced esophageal cancer
    Khaitan, Puja Gaur
    Ponnusamy, Sangeetha
    JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (12) : 2148 - 2149
  • [29] Neoadjuvant chemoradiotherapy followed by minimally invasive esophagectomy: is it a superior approach for locally advanced resectable esophageal squamous cell carcinoma?
    Tang, Han
    Zheng, Hao
    Tan, Lijie
    Shen, Yaxing
    Wang, Hao
    Lin, Miao
    Wang, Qun
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 963 - 972
  • [30] Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma
    Argalacsova, Sona
    Vocka, Michal
    Petruzelka, Lubos
    Ryska, Miroslav
    Zaruba, Pavel
    Krska, Zdenek
    Fryba, Vladimir
    Ulrych, Jan
    Cerny, Vladimir
    Tuma, Tomas
    Hoskovec, David
    NEOPLASMA, 2023, 70 (03) : 468 - 475
12345